BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35120355)

  • 21. Ascorbate lacks significant influence in rats with bile duct ligation-induced liver injury.
    Ho HL; Huo TI; Chang T; Lee WS; Hsin IF; Lee FY; Huang HC; Hou MC; Lee SD
    J Chin Med Assoc; 2017 Sep; 80(9):539-550. PubMed ID: 28684188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
    Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H
    PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Green tea polyphenol decreases the severity of portosystemic collaterals and mesenteric angiogenesis in rats with liver cirrhosis.
    Hsu SJ; Wang SS; Hsin IF; Lee FY; Huang HC; Huo TI; Lee WS; Lin HC; Lee SD
    Clin Sci (Lond); 2014 May; 126(9):633-44. PubMed ID: 24063570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
    Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.
    Zhou Q; Hennenberg M; Trebicka J; Jochem K; Leifeld L; Biecker E; Sauerbruch T; Heller J
    Gut; 2006 Sep; 55(9):1296-305. PubMed ID: 16492715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleos(t)ide Analogs Do Not Independently Influence Hepatic Fibrosis and Portal Hypertension beyond Viral Suppression in CBDL-Induced Cirrhotic Rat.
    Hsieh YH; Huang HC; Chang CC; Chuang CL; Lee FY; Hsu SJ; Huang YH; Hou MC; Lee SD
    J Pharmacol Exp Ther; 2018 Nov; 367(2):260-266. PubMed ID: 30194095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant inhibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats.
    Lee PC; Yang YY; Huang CS; Hsieh SL; Lee KC; Hsieh YC; Lee TY; Lin HC
    Hepatol Res; 2015 May; 45(5):578-88. PubMed ID: 24961937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
    Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
    United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats.
    Huang HC; Hsu SJ; Chang CC; Chuang CL; Hou MC; Lee FY
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
    Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Chang T; Huang HC; Lee FY; Lee SD
    Eur J Pharmacol; 2017 May; 802():36-43. PubMed ID: 28238769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.
    Chang CC; Chuang CL; Tsai MH; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumol Attenuates Portal Hypertension and Collateral Shunting Via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
    Wang X; Li J; Nong J; Deng X; Chen Y; Wu P; Huang X
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38438779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezetimibe treatment reduces oxidized low-density lipoprotein in biliary cirrhotic rats.
    Chang CC; Huang HC; Hsu SJ; Pun CK; Chuang CL; Hou MC; Lee FY
    J Chin Med Assoc; 2024 May; 87(5):463-470. PubMed ID: 38380910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
    Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis.
    Hsin IF; Lee JY; Huo TI; Lee FY; Huang HC; Hsu SJ; Wang SS; Ho HL; Lin HC; Lee SD
    J Gastroenterol Hepatol; 2016 May; 31(5):1045-51. PubMed ID: 26474184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cirrhotic Endothelial Progenitor Cells Enhance Liver Angiogenesis and Fibrosis and Aggravate Portal Hypertension in Bile Duct-Ligated Cirrhotic Rats.
    Tripathi DM; Hassan M; Siddiqui H; Kaur I; Rawal P; Bihari C; Kaur S; Sarin SK
    Front Physiol; 2020; 11():617. PubMed ID: 32595520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of portacaval shunting on hyperdynamic circulation in bile duct-ligated cirrhotic rats.
    Wong J; Zhang Y; Lee SS
    J Hepatol; 1997 Feb; 26(2):369-75. PubMed ID: 9059959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of proton pump inhibitor on hepatic vascular responsiveness and hemodynamics in cirrhotic rats.
    Hsin IF; Hsu SJ; Chuang CL; Huo TI; Huang HC; Lee FY; Ho HL; Chang SY; Lee SD
    J Chin Med Assoc; 2018 Jul; 81(7):585-592. PubMed ID: 29780000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.